02Mar/23
Oncolytic Virus T-VEC Shows Excellent Efficacy in Clinical Trials for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) accounts for approximately 15% of all breast cancer cases. Compared with other types of breast cancer, TNBC is more likely to spread, metastasize, and recur, and as itRead More…